{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T10:32:37Z","timestamp":1769077957265,"version":"3.49.0"},"reference-count":6,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Acute pericarditis represents an inflammatory disease affecting the pericardial layers. In developed countries more than 80% of pericarditis are defined as idiopathic, less frequently they are secondary to other conditions such as infections, rheumatic or systemic inflammatory diseases, cancer, post\u2013cardiac injury syndromes and radiation therapy (RT).<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We reported a case of a patient with acute pericarditis that occurred a few hours after chest radiation therapy, performed for breast cancer. After the failure of first-line therapy, we introduced anakinra, an anti- interleukin-1 (IL-1) agent, observing an immediate clinical and instrumental response.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our experience highlights the efficacy and safety profile of anakinra in early stages of acute pericarditis with an inflammatory phenotype. To the best of our knowledge, there is no data supporting the use of anakinra in the treatment of RT induced acute pericarditis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2024.1491361","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T04:31:27Z","timestamp":1728880287000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of anakinra in radiation-induced acute pericarditis: a case report"],"prefix":"10.3389","volume":"11","author":[{"given":"Ludovico Luca","family":"Sicignano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celeste Ambra","family":"Murace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Palazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Verrecchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Grazia","family":"Massaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Manna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Gerardino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1093\/eurheartj\/ehv479","article-title":"The 2015 ESC guidelines on the diagnosis and management of pericardial diseases","volume":"36","author":"Adler","year":"2015","journal-title":"Eur Heart J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jacc.2019.11.021","article-title":"Management of acute and recurrent pericarditis: JACC state-of-the-art review","volume":"75","author":"Chiabrando","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s11886-023-01933-3","article-title":"Radiation-induced pericardial disease: mechanisms, diagnosis, and treatment","volume":"25","author":"von Kemp","year":"2023","journal-title":"Curr Cardiol Rep"},{"key":"B4","volume-title":"Radiation-Induced Cardiac Toxicity","author":"Hufnagle","year":"2023"},{"key":"B5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/FJC.0000000000000847","article-title":"Acute effects of interleukin-1 blockade using anakinra in patients with acute pericarditis","volume":"76","author":"Wohlford","year":"2020","journal-title":"J Cardiovasc Pharmacol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s11739-020-02627-2","article-title":"Early introduction of anakinra improves acute pericarditis and prevents tamponade in staphylococcal sepsis","volume":"16","author":"Sicignano","year":"2021","journal-title":"Intern Emerg Med"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1491361\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T04:31:28Z","timestamp":1728880288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1491361\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":6,"alternative-id":["10.3389\/fcvm.2024.1491361"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1491361","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,14]]},"article-number":"1491361"}}